IP Library Assignment 063399/0892
Patent Assignment
Reel/Frame 063399/0892

Invention Assignment Agreement (Employment)

Recorded: 2022-10-28 Pages: 7
Assignor
NEGI, HARSH
Executed: 2014-09-16
Assignee
E. Z. BIOXCEL SOLUTIONS PVT. LTD.
7TH FLOOR, INFINITY TOWER A, DLF CYBER CITY, PHASE-II, GURGAON, HARYANA, 122002, INDIA
Covered Property (1)
Use of Sublingual Dexmedetomidine for the Treatment of Agitation
Application: 17/496,470 →
Publication: US 2022/0031663
Related Assignments (9)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest Apr 19, 2022
From: BIOXCEL THERAPEUTICS, INC.
To: OAKTREE FUND ADMINISTRATION, LLC
Reel/Frame 059726/0788 →
Security Interest Apr 19, 2022
From: BIOXCEL THERAPEUTICS, INC.
To: OAKTREE FUND ADMINISTRATION, LLC
Reel/Frame 059727/0964 →
Assignment of Assignor's Interest May 9, 2022
From: E.Z. BIOXCEL SOLUTIONS PVT. LTD.
To: BIOXCEL THERAPEUTICS, INC.
Reel/Frame 059874/0287 →
Assignment of Assignor's Interest Oct 28, 2022
From: SHARMA, SAMEER
To: E. Z. BIOXCEL SOLUTIONS PVT. LTD.
Reel/Frame 061582/0936 →
Invention Assignment Agreement (Employment) Oct 28, 2022
From: SAINI, DEEPA
To: E. Z. BIOXCEL SOLUTIONS PVT. LTD.
Reel/Frame 062350/0935 →
Assignment of Assignor's Interest Oct 28, 2022
From: YOCCA, FRANK
To: BIOXCEL THERAPEUTICS, INC.
Reel/Frame 061583/0089 →
Assignment of Assignor's Interest Oct 28, 2022
From: NANDABALAN, KRISHNAN
To: BIOXCEL CORPORATION
Reel/Frame 061582/0793 →
Assignment of Assignor's Interest Oct 28, 2022
From: BIOXCEL CORPORATION
To: BIOXCEL THERAPEUTICS, INC.
Reel/Frame 061582/0841 →
Security Interest Sep 11, 2024
From: BIOXCEL THERAPEUTICS, INC.
To: OAKTREE FUND ADMINISTRATION, LLC
Reel/Frame 068938/0906 →